V VRTX

Vertex Pharmaceuticals Inc

BIOTECHNOLOGY · HEALTHCARE

Vertex Pharmaceuticals Inc. is a leading biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development of innovative therapies for serious diseases, primarily cystic fibrosis (CF). Renowned for its pioneering work in CF treatments, Vertex has made significant stri...

$434.30

-1.01% ($4.41)

Volume 948,793

52W High $510.77

52W Low $362.50

Market Cap $118.26B

← Back to Calendar Compare with Others →

What to Watch This Quarter

Based on historical data

Consensus EPS

$3.91

Whisper EPS

$3.98

1.7% above consensus

Last Quarter

$5.03

Current Streak

2 Misss

Avg Surprise (4Q)

+0.01%

Next Earnings Report

Reports in 27 days

Report Date May 4, 2026

Whisper Spread +1.66%

Consensus Estimate

$3.91

Official analyst average

Whisper Number

$3.98

What traders expect

Bullish Sentiment: The whisper number is 1.7% above consensus, suggesting traders expect a strong beat. The stock may be priced for upside surprise.

Price Chart

EPS History: Consensus vs Actual

Last 12 quarters

Price Movement Around Earnings

Q4 2025 Feb 12, 2026

1-Day: +5.69%

5-Day: +2.65%

Q4 2025 Feb 4, 2026

1-Day: -2.49%

5-Day: +0.07%

Q3 2025 Nov 10, 2025

1-Day: +1.90%

Q2 2025 Aug 4, 2025

1-Day: -20.60%

Revenue & Financial Performance

Revenue Whisper

$3.20B

TWN Proprietary Estimate

Last Quarter Revenue

$3.23B

+10.8% YoY

Gross Margin

85.6%

Net Margin: 36.9%

Quarter	Revenue	YoY Growth	Gross Margin	Op Margin	Net Income
Q4'25	$3.23B	+10.8%	85.6%	40.3%	$1.19B
Q3'25	$3.08B	+11.0%	86.5%	38.6%	$1.08B
Q2'25	$2.96B	+12.1%	86.3%	38.8%	$1.03B
Q1'25	$2.77B	+3.1%	86.9%	22.8%	$646.3M
Q4'24	$2.91B	+15.7%	85.5%	35.2%	$913.0M
Q3'24	$2.77B	+11.6%	85.8%	40.3%	$1.05B
Q2'24	$2.65B	+6.1%	85.9%	-132.9%	-$3.59B
Q1'24	$2.69B	+13.2%	87.3%	42.4%	$1.10B

Historical Earnings

Last 12 quarters

Quarter	Date	Consensus	Whisper	Actual EPS	Surprise %	Result
Q4 2025	Feb 12, 2026	$5.15	$4.70	$5.03	-2.33%	Beat
Q4 2025	Feb 4, 2026	$5.12	$5.23	$5.03	-1.76%	Missed
Q3 2025	Nov 10, 2025	$4.61	$4.69	$4.80	+4.12%	Beat
Q2 2025	Aug 4, 2025	$4.25	$3.61	$4.52	+6.35%	Beat
Q1 2025	May 5, 2025	$4.29	$3.65	$4.06	-5.36%	Beat
Q4 2024	Feb 10, 2025	$4.02	$3.42	$3.98	-1.00%	Beat
Q3 2024	Nov 4, 2024	$4.13	$3.51	$4.38	+6.05%	Beat
Q2 2024	Aug 1, 2024	$2.94	$3.06	-$12.83	--	Missed
Q1 2024	May 6, 2024	$4.06	$4.20	$4.76	+17.24%	Beat
Q4 2023	Feb 5, 2024	$4.10	$4.23	$4.20	+2.44%	Met
Q3 2023	Nov 6, 2023	$3.97	$4.10	$4.08	+2.77%	Met
Q2 2023	Aug 1, 2023	$3.88	$4.06	$3.89	+0.26%	Missed